Your browser doesn't support javascript.
loading
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.
Golan, Shay; Bar, Vered; Salpeter, Seth J; Neev, Guy; Creiderman, German; Kedar, Daniel; Aharon, Sara; Turovsky, Lubov; Zundelevich, Adi; Shahar, Hamutal; Shapira, Hagit; Mallel, Giuseppe; Stossel, Erez; Gavert, Nancy; Straussman, Ravid; Dotan, Zohar; Berger, Raanan; Stossel, Chani; Golan, Talia; Halperin, Sharon; Leibovici, Dan; Breuer, Shani; Rottenberg, Yakir; Applebaum, Liat; Hubert, Ayala; Nechushtan, Hovav; Peretz, Tamar; Zick, Aviad; Chertin, Boris; Koulikov, Dmitry; Sonnenblick, Amir; Rosenbaum, Eli.
Affiliation
  • Golan S; Department of Urology, Beilinson Hospital - Rabin Medical Center, Petah Tikva, Israel.
  • Bar V; Curesponse, Rehovot, Israel.
  • Salpeter SJ; Curesponse, Rehovot, Israel.
  • Neev G; Curesponse, Rehovot, Israel.
  • Creiderman G; Department of Urology, Beilinson Hospital - Rabin Medical Center, Petah Tikva, Israel.
  • Kedar D; Department of Urology, Beilinson Hospital - Rabin Medical Center, Petah Tikva, Israel.
  • Aharon S; Curesponse, Rehovot, Israel.
  • Turovsky L; Curesponse, Rehovot, Israel.
  • Zundelevich A; Curesponse, Rehovot, Israel.
  • Shahar H; Curesponse, Rehovot, Israel.
  • Shapira H; Curesponse, Rehovot, Israel.
  • Mallel G; Curesponse, Rehovot, Israel.
  • Stossel E; Curesponse, Rehovot, Israel.
  • Gavert N; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel.
  • Straussman R; Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel.
  • Dotan Z; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Berger R; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Stossel C; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Golan T; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Halperin S; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Leibovici D; Department of Urology, Kaplan Medical Center, Rehovot, Israel.
  • Breuer S; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Rottenberg Y; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Applebaum L; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Hubert A; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Nechushtan H; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Peretz T; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Zick A; Sharett Institute of Oncology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Chertin B; Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Koulikov D; Department of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Sonnenblick A; Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Rosenbaum E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Front Med (Lausanne) ; 10: 1221484, 2023.
Article in En | MEDLINE | ID: mdl-37840996

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Med (Lausanne) Year: 2023 Document type: Article Affiliation country: Israel Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Med (Lausanne) Year: 2023 Document type: Article Affiliation country: Israel Country of publication: Suiza